CECCARONI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 55
EU - Europa 43
AS - Asia 27
SA - Sud America 12
AF - Africa 1
Totale 138
Nazione #
US - Stati Uniti d'America 55
IT - Italia 18
RU - Federazione Russa 15
SG - Singapore 13
BR - Brasile 10
CN - Cina 9
FI - Finlandia 5
HK - Hong Kong 3
BE - Belgio 1
DE - Germania 1
DZ - Algeria 1
EC - Ecuador 1
IE - Irlanda 1
IN - India 1
PL - Polonia 1
SA - Arabia Saudita 1
SE - Svezia 1
UY - Uruguay 1
Totale 138
Città #
Chandler 9
Naples 8
Ashburn 6
Singapore 6
Los Angeles 4
Princeton 4
Beijing 3
Hong Kong 3
Turku 3
Columbus 2
Dallas 2
Houston 2
Lappeenranta 2
Menlo Park 2
Tomsk 2
Woodbridge 2
Altos 1
Angri 1
Baronissi 1
Barueri 1
Boardman 1
Brooklyn 1
Campo Mourão 1
Chlef 1
Cormano 1
Cuenca 1
Dublin 1
Englewood 1
Faenza 1
Fremont 1
Hefei 1
Itapetininga 1
Jauru 1
Mangaratiba 1
Medina 1
Montevideo 1
Moscow 1
Munich 1
Palhoça 1
Parauapebas 1
Pignola 1
Pune 1
Rome 1
Salt Lake City 1
San Diego 1
San Francisco 1
Santa Clara 1
Stockholm 1
Sumaré 1
The Dalles 1
Tucson 1
Uberlândia 1
Warsaw 1
Washington 1
Totale 98
Nome #
Clinical Evaluation of the Efficacy and Tolerability of Rigenase® and Polyhexanide (Fitostimoline® Plus) vs. Hyaluronic Acid and Silver Sulfadiazine (Connettivina® Bio Plus) for the Treatment of Acute Skin Wounds: A Randomized Trial 70
Injection Treatments for Vulvovaginal Atrophy of Menopause: A Systematic Review 30
Metastatic Renal Cell Carcinoma to the Soft Tissue 27 Years after Radical Nephrectomy: A Case Report 26
Reply to De Luca et al. Comment on "Marra et al. Metastatic Renal Cell Carcinoma to the Soft Tissue 27 Years after Radical Nephrectomy: A Case Report. Medicina 2023, 59, 150" 18
Totale 144
Categoria #
all - tutte 879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 0 0 0 0 0 0 14
2022/202330 8 4 0 3 1 2 3 4 5 0 0 0
2023/202428 1 3 2 6 1 6 0 2 0 4 0 3
2024/202565 0 4 0 1 1 10 13 2 7 6 15 6
2025/20267 7 0 0 0 0 0 0 0 0 0 0 0
Totale 144